Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining -0.17% today. In the last week its performance is -3.71%, and 3.93% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 70.78, so today’s gain of -0.17% is a significant step towards its target price. The GAP today is therefore -0.06%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 105399.59, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 71.90%.
At the current price of 64.61, it has a dividend yield of 3.53%, and its target price is 70.78. This is with a profit margin of 23.10%, and total debt/equity of 6.71. AbbVie Inc. (NYSE:ABBV) has a P/E of 18.52, as well as a forward P/E of 11.33.
With a current EPS of 3.49, and a forecasted EPS growth for next year at 18.66%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 16.25%.
Performance for the year is 4.03%. Since its IPO date on 1/2/2013, the total performance to date is 12.25%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 7027402, while its average volume is 7974.64. Whilst the total gain today was -0.17%, it did have a day high of -5.15%.
Volatility for this week has been at 1.85%, and 1.42% for the month. The 52-week low for AbbVie Inc., ABBV has been 46.30%, while the 52-week-high has reached -5.15%.
Looking at its return of investments, which is 16.90%, and its return on assets is 10.00%. AbbVie Inc. (NYSE:ABBV) has an operating margin of 35.00%. With a sales growth of 17.80% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is 6.62, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.14, and the P/S is 4.26, along with a P/B of 18.62. Meanwhile it has a p/cash of 13.17.